Celularity

@celularity

Transforming lives by harnessing the power of placenta-derived cells and tissues to amplify the body’s ability to fight disease and regenerate itself

Vrijeme pridruživanja: kolovoz 2016.

Tweetovi

Blokirali ste korisnika/cu @celularity

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @celularity

  1. Prikvačeni tweet
    11. tra 2019.

    Today we announced a lease agreement for a new state-of-the-art manufacturing facility and integrated campus in . Learn more about our plans

    Poništi
  2. proslijedio/la je Tweet
    4. velj

    With Ambassador Hwang, Hank Greenberg and Chief Science Officer Xiaokui Zhang

    Poništi
  3. 29. sij

    Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection

    Poništi
  4. 28. sij

    The FDA clearance of our IND application for CYNK-001 allows us to initiate the first U.S. clinical investigation of an allogeneic NK Cell therapy administered intravenously or intratumorally in patients with Multiforme. Learn more:

    Poništi
  5. proslijedio/la je Tweet
    28. sij

    John Sculley (), former CEO turned high-tech investor, places founder/CEO Robert Hariri () as a "visionary" in same league as Steve Jobs! Here's my interview of Dr. Hariri during 2019

    Poništi
  6. 22. sij

    Today we announced FDA clearance of our IND application for CYNK-001, an allogeneic, off-the-Shelf, cryopreserved NK Cell Therapy as treatment for Multiforme:

    Poništi
  7. proslijedio/la je Tweet
    12. sij

    Placental stem cell derived NK cells are effective against multiple myeloma - Myeloma Research News Preliminary results from Phase 1 trial look promising

    Poništi
  8. proslijedio/la je Tweet

    -007 Treatment After Leads to Good Response Rates in Multiple Patients, early trial data shows

    Poništi
  9. 23. pro 2019.

    Happy Holidays from Celularity!

    Poništi
  10. 11. pro 2019.

    ICYMI, we introduced new pre-clinical data from our CAR T and NK cell therapy programs at . Learn more:

    Poništi
  11. 10. pro 2019.

    Thank you to everyone who connected with us at . We enjoyed discussing data from our genetically-modified NK- and T cell-based programs. Celularity is committed to advancing innovation in !

    Poništi
  12. 9. pro 2019.

    Today we announced new pre-clinical and clinical data that further demonstrates the versatility of our allogeneic, off the shelf, placental-derived cell therapy platform. Learn more about the new clinical and pre-clinical data presented at :

    Poništi
  13. 5. pro 2019.

    Attending ? Don’t forget to stop by our poster and learn more about the exciting updates from our oncology programs.

    Poništi
  14. 4. pro 2019.

    We're proud to share that recently, our CEO, , was awarded a 2019 Genius Innovators Award by the . Help us congratulate him and the other award recipients , , and on this incredible honor!

    Poništi
  15. proslijedio/la je Tweet

    . is one of the honorees at on Dec. 2. The Chairman, Founder & CEO of , Hariri is pioneering the use of stem cells to cure disease and slow aging. Learn more:

    Poništi
  16. 26. stu 2019.

    At Celularity, we're working to develop novel invesgiational therapies for those with , acute myeloid , and . Learn more about us and our approach:

    Poništi
  17. 22. stu 2019.

    Learn more about the preclinical data we are presenting at supporting our proprietary PNK allogeneic cell therapy platform as an investigational treatment in development for .

    Poništi
  18. 19. stu 2019.

    We look forward to participating in in Phoenix, Arizona. Visit our poster presentation on Nov. 22nd to learn more about the potential of our proprietary PNK allogeneic cell therapy platform as an Investigational treatment in development for .

    Poništi
  19. 11. stu 2019.

    We had a productive time at ! Thanks to all who came to our posters and met with us to discuss innovative technologies and novel investigational treatments. It's an exciting time for cell-based . We look forward to next year's meeting.

    Poništi
  20. 8. stu 2019.

    Today we're at 's Seventh Annual C-Suite Summit to discuss ways to drive medical innovation and bring better treatments to patients with other industry leaders. Learn more about the event:

    Poništi
  21. 7. stu 2019.

    We are excited to share our innovative research at . Be sure to check out our poster presentations on Nov. 9, 2019, highlighting new research and preclinical data from our oncology programs in and .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·